Mr Adam Petravicius > Kirkland & Ellis LLP > Chicago, United States > Lawyer Profile

Kirkland & Ellis LLP
300 NORTH LASALLE
CHICAGO, IL 60654
United States
Adam Petravicius photo

Position

Adam Petravicius is an experienced technology and IP transactions attorney with substantial experience in leading technology-driven deals. He has worked with companies of all sizes, from emerging companies to the largest public companies, in a wide range of industries, including software/IT, life sciences, electronics, consumer products, manufacturing, chemicals, defense and automotive. He routinely advises executives and business owners on strategy and legal issues, providing business-oriented advice and practical solutions to mitigate risk and maximize value.

Adam works with clients on strategic commercial transactions, joint ventures and strategic alliances, licenses, development agreements, commercialization and other collaboration agreements, technology acquisitions and sales, outsourcing, consulting and services agreements, and other complex commercial agreements. He also works closely with Kirkland’s Corporate/M&A practice in connection with the technology and IP aspects of corporate transactions, and in working with portfolio companies on the types of transactions described above.

Lawyer Rankings

United States > Intellectual property > Patents: licensing

Kirkland & Ellis LLP‘s extensive track record acting for licensors and licensees alike nourishes the practice with strong capabilities to negotiate mandates with a deep understanding of both perspectives. In addition to negotiating license agreements, the group is well versed in other commercial arrangements that are often implemented alongside of patent licensing deals, including joint development agreements, supply agreements, and service and technical assistance agreements. The team offers additional expertise in the development and implementation of patent licensing programs, often by way of corporate transactions. Key practitioners include David MacDonald in New York, who has a focus on pharmaceutical and biotechnology companies; Chicago-based trio Russell Levine, Adam Petravicius, and Seth Traxler, who leads the technology & IP transactions practice; and Shellie Freedman in New York, whose background in molecular and cell biology provides her with additional insight into life sciences transactions.